Literature DB >> 4287056

Trophoblastic disease. Concepts of management.

F C Westerhout.   

Abstract

Trophoblastic tumors are a notoriously unpredictable group in which metastasis may occur from histologically benign tumors and cause death, whereas a histologically malignant tumor may spontaneously disappear. Additional problems are created by the inability to accurately establish a diagnosis before abortion of molar tissue or development of metastasis.In recent years chemotherapy has dramatically improved the prognosis of patients with choriocarcinoma. This fact, plus the importance of the time interval between onset of disease and the beginning of chemotherapy, makes close follow-up of patients with trophoblastic tumors imperative.Concepts of therapy for trophoblastic tumors are rapidly changing. Indications for chemotherapy are broadening, especially in the areas of persistent and metastatic trophoblastic disease. As surgical intervention in the form of hysterectomy is becoming less important, the reproductive capacity of these young women is being preserved. Astute diagnosis, appropriate therapy and active life-long follow-up are the essentials in the management of patients with trophoblastic disease.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4287056      PMCID: PMC1516263     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  16 in total

1.  Choriocarcinoma. Absolute 5 year survival rates of 122 patients treated by hysterectomy.

Authors:  J I BREWER; R T SMITH; G B PRATT
Journal:  Am J Obstet Gynecol       Date:  1963-04-01       Impact factor: 8.661

2.  ABNORMAL URINARY ESTROGEN LEVELS IN HYDATIDIFORM MOLES DETERMINED BY GAS-LIQUID CHROMATOGRAPHY.

Authors:  P BONANNO; A A PATTI; T F FRAWLEY; A A STEIN
Journal:  Am J Obstet Gynecol       Date:  1963-09-15       Impact factor: 8.661

3.  REPEAT HYDATIDIFORM MOLES. REPORT OF SEVEN CASES.

Authors:  C T HSU; C H LAI; C L CHANGCHIEN; B C CHANGCHIEN
Journal:  Am J Obstet Gynecol       Date:  1963-10-15       Impact factor: 8.661

4.  Metastases in benign hydatidiform mole and chorioadenoma destruens.

Authors:  C T HSU; L C HUANG; T Y CHEN
Journal:  Am J Obstet Gynecol       Date:  1962-12-01       Impact factor: 8.661

5.  Metastasizing benign trophoblastic tumors.

Authors:  R A THIELE; R R DE ALVAREZ
Journal:  Am J Obstet Gynecol       Date:  1962-12-01       Impact factor: 8.661

6.  Pregnancies following chemically treated choriocarcinoma.

Authors:  H L FREEDMAN; A MAGAGNINI; M GLASS
Journal:  Am J Obstet Gynecol       Date:  1962-06-15       Impact factor: 8.661

7.  [Estrogen and pregnanediol excretions in hydatidiform mole].

Authors:  H ERB; M KELLER; G A HAUSER; R WENNER
Journal:  Gynaecologia       Date:  1961

8.  Choriocarcinoma. Observations on the etiology.

Authors:  J S SCOTT
Journal:  Am J Obstet Gynecol       Date:  1962-01-15       Impact factor: 8.661

9.  Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women.

Authors:  R HERTZ; J LEWIS; M B LIPSETT
Journal:  Am J Obstet Gynecol       Date:  1961-09       Impact factor: 8.661

10.  Quantitative chorionic gonadotrophin; prognostic value in hydatidiform mole and chorionepithelioma.

Authors:  E DELFS
Journal:  Obstet Gynecol       Date:  1957-01       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.